Teva Pharmaceutical Industries (TEVA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist

17.460
-0.210-1.19%

Close Oct 2 16:00 ET

17.500
+0.040+0.23%

Pre 09:15 ET

19.78BMarket Cap-44769P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Teva and MAbxience Expand Strategic Partnership to Include an Additional Oncology Biosimilar Candidate
GlobeNewswire52minutes ago
BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22
Moomoo NewsOct 1 20:32 ET · Ratings
Teva Pharmaceutical's US Affiliate Launches Octreotide Acetate for Injectable Suspension
MT NewswiresOct 1 09:43 ET
Teva Announces Launch Of The First And Only Generic Version Of Sandostatin LAR Depot, In The U.S.
BenzingaOct 1 08:31 ET
Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
Yahoo FinanceOct 1 03:38 ET
Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 A.m. ET on November 6, 2024
GlobeNewswireSep 30 16:30 ET

Comments

Teddy123

Sep 23 06:19

Teva Pharmaceutical's Movement Disorder Drug Shows Sustained Improvement in Extension StudyTeva Pharmaceutical (TEVA) said Monday thttps://www.moomoo.com/t/news/post/43799641/JZZ3ryFJBe

$Teva Pharmaceutical Industries (TEVA.US)$

Lnova

Sep 23 00:21

$Teva Pharmaceutical Industries (TEVA.US)$

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients With Debilitating Movement Disorder Tardive Dyskinesia

Stock_Drift

Sep 21 05:11

$Teva Pharmaceutical Industries (TEVA.US)$

Lnova

Sep 13 16:18

Teva Announces $80M Settlement to Baltimore

$Teva Pharmaceutical Industries (TEVA.US)$

Lnova: [Share Link: Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against O

Analysts Notebook

Sep 5 06:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...